Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Early Parkinson's Disease Monotherapy With CVN424 [Phase 2]
Phase 2 trial of CVN424 as monotherapy for early Parkinson's disease has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome [NA]
A completed clinical trial evaluating ketogenic diet interventions in Parkinson's disease with a focus on safeguarding the gut microbiome.
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: A Clinical Study of Dihydroergotine Mesylate Extended-release Tablets for the Treatment of Drooling in Parkinson's Disease. [Phase 4]
A Phase 4 clinical study evaluating dihydroergotine mesylate extended-release tablets for reducing drooling in Parkinson's disease has compl…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Cue X as a Treatment for People With Parkinson's Disease [NA]
The document reports a completed clinical trial evaluating Cue X as a treatment for Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Blood-Brain-Barrier Disruption With Cerezyme in Patient's With Parkinson's Disease [NA]
A clinical trial evaluating blood-brain barrier disruption using Cerezyme (imiglucerase) in Parkinson disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: A Feasibility Study on the Safety and Preliminary Efficacy of Bilateral Subthalamotomy Using MRgFUS for Treatment of PD [NA]
A completed feasibility study evaluating the safety and preliminary efficacy of bilateral subthalamotomy using MR-guided focused ultrasound …
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Bright Light Therapy for Non-motor Symptoms in Parkinson's Disease [NA]
The completed clinical trial from the Chinese University of Hong Kong evaluated bright light therapy for non-motor symptoms in Parkinson dis…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Adaptive Deep Brain Stimulation (aDBS) Study (Early Adapter) Part II [NA]
This update reports the completion of an Adaptive Deep Brain Stimulation (aDBS) study in Parkinson's disease by Medtronic Neuro, with result…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Effectiveness of STIL Orthosis in PD [NA]
A completed clinical trial assessed the effectiveness of the STIL Orthosis in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Split-belt Treadmill Training for Freezing of Gait in Parkinson's Disease [NA]
A completed clinical trial (NCT05511597) from KU Leuven evaluated split-belt treadmill training for freezing of gait in Parkinson's disease.…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Exploring the Effects of Spinal Cord Stimulation in Parkinson's Disease. [NA]
A completed clinical trial evaluated the effects of spinal cord stimulation in Parkinson disease. The snippet does not report the trial resu…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease [Phase 2]
Phase 2 trial evaluating citalopram as a posterior cortical protective therapy in Parkinson disease has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: UB-312 in Patients With Synucleinopathies [Phase 1]
Phase 1 trial of UB-312 in synucleinopathies (Parkinson's disease and Multiple System Atrophy) has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease. [Phase 2]
A Phase 2 randomized, placebo-controlled trial evaluated pimavanserin for impulse control disorders in Parkinson's disease; the study status…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease [NA]
A completed clinical trial evaluated vibrational therapy to improve gait and balance in Parkinson's disease; results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease [Phase 2]
Phase 2 clinical trial evaluating metformin for Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Allopregnanolone as a Regenerative Treatment for Parkinson's Disease [Phase 1]
A Phase 1 clinical trial evaluating allopregnanolone as a regenerative treatment for Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL) [Phase 1, Phase 2]
This is an update on a Phase 1/2a trial of PR001 (LY3884961) in Parkinson disease patients with a GBA1 mutation (PROPEL). The study is curre…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease. [Phase 1]
Phase 1 trial evaluating safety, tolerability, feasibility and preliminary efficacy of NouvNeu001 (human dopaminergic progenitor cell inject…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease [Phase 4]
This clinical trial update reports the termination of a Phase 4 study evaluating safinamide's effect on sleep quality in patients with Parki…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Aerobic Exercise in Parkinson's Disease [NA]
The update notes the completion of an aerobic exercise trial in Parkinson's disease and that results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Oxyhydrogen Nanobubble Infusion as a Complementary Therapy in Patients With Parkinsonism [Phase 2, Phase 3]
A clinical trial update announces the completion of Phase 2 and Phase 3 studies assessing oxyhydrogen nanobubble infusion as a complementary…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Tackling Anxiety-related Freezing of Gait in People With Parkinson's Disease [NA]
Clinical trial update on a completed study investigating anxiety-related freezing of gait in people with Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Low-Fidelity Driving Simulator Training in Parkinson's Disease. [NA]
A clinical trial update describes a study on low-fidelity driving simulator training for Parkinson's disease, which is currently not yet rec…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device. [EARLY_Phase 1]
Phase 1 clinical trial by Noah Tech, Corp. evaluating stem cell therapy plus a wearable brain-computer interface device for mild cognitive i…